Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Anakinra in the Management of Patients With COVID-19 Infection in Qatar: A Randomized Clinical Trial

NCT04643678 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT04643678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04643678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Anakinra in the Management of Patients With COVID-19 Infection in Qatar: A Randomized Clinical Trial
Lead sponsor
Hamad Medical Corporation
Phase
Phase 2/3
Overall status
Completed
Start date
October 30, 2020
Completion date
April 30, 2021
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, covid19, cytokine release syndrome, pneumonia, viral infection